SMS Co., Ltd. (SMSSY)
OTCMKTS
· Delayed Price · Currency is USD
4.670
-0.717 (-13.31%)
At close: Feb 18, 2025
SMS Co., Ltd. Revenue
SMS Co., Ltd. had revenue of 13.04B JPY in the quarter ending December 31, 2024, with 9.76% growth. This brings the company's revenue in the last twelve months to 59.50B, up 15.33% year-over-year. In the fiscal year ending March 31, 2024, SMS Co., Ltd. had annual revenue of 53.97B with 18.19% growth.
Revenue (ttm)
59.50B JPY
Revenue Growth
+15.33%
P/S Ratio
1.82
Revenue / Employee
14.21M JPY
Employees
4,188
Market Cap
688.12M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 53.97B | 8.31B | 18.19% |
Mar 31, 2023 | 45.67B | 6.77B | 17.40% |
Mar 31, 2022 | 38.90B | 2.94B | 8.17% |
Mar 31, 2021 | 35.96B | 820.00M | 2.33% |
Mar 31, 2020 | 35.14B | 4.30B | 13.96% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |